The mechanism of Bartonella infection involves invasion and colonization of human erythrocytes, the steps of which differ between species.14 For instance, B bacilliformis contains a unipolar flagella and is very motile, and antibodies against a component of this flagella have shown to inhibit the organism’s binding to the erythrocytes.15 In addition, this particular species uses deformin, a virulence factor that causes invaginations in the membranes of erythrocytes and allows for further success in invasion.16 This process of entry causes the Oroya fever phase in B bacilliformis infection but has no hemolytic effect in other Bartonella cases.17 Additionally, Bartonella target host endothelial cells, manifesting in angiogenesis and/or proinflammatory responses seen in B bacilliformis and bacillary angiomatosis.7,13 Â
The third diagnostic consideration is an atypical variant of angiolymphoid hyperplasia with eosinophilia (ALHE), a very plausible diagnosis in this case. Kimura disease and ALHE are conditions that involve the head and neck region, tend to recur despite treatment, and share certain histopathologic features, such as lymphoeosinophilic infiltrates of the involved tissue and vascular proliferation.18,19 Although there have been several reports of both entities occurring in a single patient,20,21 most authors view ALHE and Kimura disease as two distinct disorders.22Â
ALHE occurs in young to middle-aged women and presents with multiple small (<2 cm) erythematous dermal papules or nodules.18 The lesions are commonly superficial, localizing to the dermis or subcutis. Eosinophilia occurs in approximately 20% of patients, but other systemic manifestations are absent. Histologic examination shows a diffuse lymphoid infiltrate of diverse intensity, with a variable eosinophilic component. The vascular proliferation in ALHE is characterized by thick-walled blood vessels lined by plump epithelioid endothelial cells with vacuolated cytoplasm and vesicular nuclei, which protrude into and sometimes occlude the vascular lumens.23 In rare cases, variants of ALHE can present with worrisome histologic features suggesting angiosarcoma, including infiltrative networks of vascular channels lined by hyperchromatic atypical endothelial cells, and careful consideration must be made to differentiate this entity from angiosarcoma.24 In this case, the morphologic semblance of the well-formed vessels to those seen in ALHE would certainly suggest that this case could potentially be categorized as an atypical variant of ALHE. The main differentiating point that ultimately lead us to not render this diagnosis was the degree of single cell nonvasoformative atypical endothelial cell growth within the dermis. Due to the vascular aspect of this entity being very conspicuous, some authors have considered therapeutic intervention with β blockers. One report described a favorable treatment response with propranolol 40 mg daily.25
Kimura disease occurs mainly in young Asian men and presents with large (>2 cm) masses.19 The lesions are deep and involve subcutaneous tissue, muscle, and salivary glands. There are frequent systemic manifestations, such as lymph node enlargement, eosinophilia, and elevated serum IgE. Histopathologically, Kimura disease show a significant pattern of reactive lymphoid hyperplasia including conspicuous germinal centers and tissue eosinsophilia.26 A vascular proliferation may be present, but the characteristic cytomorphologic alterations of the endothelium seen in ALHE are not identified.
Serologic findings in these closely related conditions include high IgE levels and peripheral blood eosinophilia. Given the findings of clonality in some cases, certain phenotypic abnormalities, such as a loss of CD7 (personal observations), the lack of an antigenic trigger, recalcitrance to sustained remission with standard lympholytic therapy (eg, steroids) along with synchronous and or metachronous T-cell lymphoma, it is reasonable to suggest that this condition, especially when presenting with marked and intractable facial infiltration (ie, Kimura disease) might be considered under the rubric of a form of low-grade T-cell dyscrasia.27-29Â
The final consideration and favored diagnosis are in the context of eruptive angiomatous nodule. The cutaneous angiomatous epithelioid nodule is an important entity to recognize because the extent of endothelial cell atypia can at times be significant, and if one is not cognizant of the entity, one can potentially misdiagnose such cases as representing epithelioid angiosarcoma.30 In the original paper, the authors reviewed all of their consultation files over a 13-year period, demonstrating 15 examples of an entity that appeared to have a uniform clinical and histopathologic presentation.30 The medium age of presentation was 37 years (range, 15-79 years), hence involving a demographic population different than the tufted angioma, the Dabska tumor, and the Kaposiform hemangioendothelioma, all of which can show significant areas of solid epithelioid endothelial cell growth. The lesions developed over time and mostly presented as a solitary bluish nodule or papule that rarely exceeded 1.0 cm in size. In fact, the median diameter was 0.5 cm. The lesions could be distributed over the trunk, extremities, and face. The most commonly affected sites, however, were trunk and extremities. Of the 15 cases,30 one patient developed multiple lesions but confined to the same geographic site. The fact that this patient was taking exogenous testosterones and engaged in rigorous contact sports could be a pathophysiologic trigger in the evolution of this benign eruptive vasoformative process. In particular, rat studies have shown that exogenous testosterone is associated with increased levels of vascular endothelial cell growth factor and increased numbers of endothelial progenitor cells,31,32 with one study showing that testosterone and voluntary exercise promoted angiogenesis in the hearts of rats by enhancing expression of vascular endothelial cell growth factor.33
The histopathology of the cutaneous epithelioid angiomatous nodule is highly distinctive with all of the salient features being summarized by the original index paper by Brenn and Fletcher.30 The lesions are typically well circumscribed and show a nodular appearance; the nodule is usually unilobular as opposed to multinodular and is composed predominantly of a solid, sheet-like proliferation of large polygonal epithelioid cells containing abundant eosinophilic to clear cytoplasm with vesicular nuclei and prominent nucleoli. However, there can be a well-defined vasoformative component that resembles the vascular channels found in ALHE. As with ALHE, endothelial cells exhibit intracytoplasmic vacuoles that are quite numerous. Mitotic figures can be seen, but they are not atypical and high-grade nuclear atypia is not present.Â
While these lesions are typically solitary, there have been several papers published that describe multicentric forms of cutaneous epithelioid angiomatous nodules.34-38 In these cases, multiple metachronous epithelioid angiomatous nodules developed over a 1- to 2-year period. The locations of these lesions include the scalp, neck, chest, and forearms. In one case of multiple cutaneous epithelioid angiomatous nodules of the forearm, treatment with a combination of cryotherapy and excision resulted in resolution without recurrence after 3 months’ follow-up.38Â
Conclusion
In summation, we have presented an unusual case of an atypical but benign eruptive angiomatous process in a young man. While there were certain features of ALHE, ultimately, we felt that the best clinical pathologic correlative diagnosis was one of eruptive angiomatous nodules, recognizing that there is likely a very fine line of distinction between atypical variants of ALHE and eruptive angiomatous nodules. The role of exogenous testosterone coupled with vigorous exercise as a trigger is worthy of further exploration.
Dr Kubiak is with the department of pathology and laboratory medicine at Weill Cornell Medicine in New York City, NY. Dr Kyriakides is a physician in the department of dermatology at St. Barnabas Hospital in Bronx, NY. Dr Jacobs is in private practice in dermatology and laser surgery in New York City. Dr Magro is a distinguished professor of pathology and laboratory medicine in the department of pathology at Weill Cornell Medicine in New York, NY, and section editor of The Dermatopathologist in The Dermatologist.
Disclosures: The authors report no relevant financial relationships.
References
1. Requena L, Sangueza OP. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J Am Acad Dermatol. 1998;38(2 Pt 1):143-175. doi:10.1016/s0190-9622(98)70237-3
2. Berger TG, Dawson NA. Angioendotheliomatosis. J Am Acad Dermatol 1988;18(2 Pt 2):407-412. doi:10.1016/S0190-9622(88)70058-4
3. Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev. 1997;10(2):203-219.Â
4 . Hart J, Mandavilli S. Epithelioid angiosarcoma: a brief diagnostic review and differential diagnosis. Arch Pathol Lab Med. 2011;135(2):268-272. doi:10.1043/1543-2165-135.2.268
5. Clarke LE, Julian KG, Clarke JT, Ioffreda MD. Reactive angioendotheliomatosis in association with a well-diffferentiated angiosarcoma. Am J Dermatopathol. 2005;27(5):422-427. doi:10.1097/01.dad.0000159214.70183.0d
6. Cheuk W, Wong KOY, Wong CSC, Dinkel JE, Ben-Dor D, Chan JKC. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004;121(3):335-342. doi:10.1309/B8TC-0LBV-H8XY-5MFV
7. Garcia FU, Wojta J, Broadley KN, Davidson JM, Hoover RL. Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. Am J Pathol. 1990;136(5):1125-1135.Â
8. Sanchez Clemente N, Ugarte-Gil CA, Solórzano N, Maguiña C, et al. Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination. PLoS Negl Trop Dis. 2012;6(10):e1819. doi:10.1371/journal.pntd.0001819.
9. Minnick MF, Anderson BE, Lima A, Battisti JM, Lawyer PG, Birtles RJ. Oroya fever and verruga peruana: bartonelloses unique to South America. PLoS Negl Trop Dis. 2014;8(7):e2919. doi:10.1371/journal.pntd.0002919.
10. Neves ES, Mendenhall IH, Borthwick SA, Su YCF, Smith GJD. Detection and genetic characterization of diverse Bartonella genotypes in the small mammals of Singapore. Zoonoses Public Health. 2018;65(1):e207-e215.
11. Kosoy M, Bai Y. Bartonella bacteria in urban rats: a movement from the jungles of Southeast Asia to metropoles around the globe. Front Ecol Evol. 2019;7:88. doi:10.3389/fevo.2019.00088
12. Kosek M, Lavarello R, Gilman RH, et al. Natural history of infection with Bartonella bacilliformis in a nonendemic population. J Infect Dis. 2000;182(3):865-872. doi:10.1086/315797
13. LeBoit PE, Berger TG, Egbert BM, Beckstead JH, Yen TSB, Stoler MH. Bacillary angiomatosis: the histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol. 1989;13(11):909-920.Â
14. Harms A, Dehio C. Intruders below the radar: molecular pathogenesis of Bartonella spp. Clin Microbiol Rev. 2012;25(1):42-78. doi:10.1128/CMR.05009-11
15. Scherer DC, Deburon-Connors I, Minnick MF. Characterization of Bartonella bacilliformis flagella and effect of antiflagellin antibodies on invasion of human erythrocytes. Infect Immun. 1993;61(12):4962-4971. doi:10.1128/IAI.61.12.4962-4971.1993
16. Mernaugh G, Ihler GM. Deformation factor: an extracellular protein synthesized by the Bartonella bacilliformis that deforms erythrocyte membranes. Infect Immun. 1992;60(3):937-943.Â
17. Xu Y-H, Lu Z-Y, Ihler GM. Purification of deformin, an extracellular protein synthesized by Bartonella bacilliformis which causes deformation of erythrocyte membranes. Biochim Biophys Act. 1995;1234(2):173-183. doi:10.1016/0005-2736(94)00271-p
18. Chitrapu P, Patel M, Readinger A, Menter A. Angiolymphoid hyperplasia with eosinophilia. Proc (Bayl Univ Med Cent). 2014;27(4):336-337. doi:10.1080/08998280.2014.11929150
19. Dhingra H, Nagpal R, Baliyan A, Alva SR. Kimura disease: case report and brief review of literature. Med Pharm Reports. 2018;92(2):195-199. doi:10.15386/cjmed-1030
20. Reddy PKS, Prasad ALS, Sumathy TK, Shivaswamy KN, Ranganathan C. An overlap of angiolymphoid hyperplasia with eosinophilia and Kimura’s disease: successful treatment of skin lesions with cryotherapy. Indian J Dermatol. 2015;60(2):216. doi:10.4103/0019-5154.152574
21. Chong WS, Thomas A, Goh CL. Kimura’s disease and angiolymphoid hyperplasia with eosinophilia: two disease entities in the same patient: case report and review of the literature. Int J Dermatol. 2006;45(2):139-145. doi:10.1111/j.1365-4632.2004.02361.x
22. Helander SD, Peters MS, Kuo TT, Su WP. Kimura’s disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol. 1995;22(4):319-326. doi:10.1111/j.1600-0560.1995.tb01414.x
23. Olsen TG, Helwig EB. Angiolymphoid hyperplasia with eosinophilia: a clinicopathologic study of 116 patients. J Am Acad Dermatol. 1985;12:781-796. doi:10.1016/s0190-9622(85)70098-9
24. Zeitouni NC, Hanna S, Loree TR, Brooks J, Cheney RT. Angiolymphoid hyperplasia with eosinophilia: a classic clinical presentation with histologic features of angiosarcoma. Dermatologic Surg. 2002;28(8):772-775. doi:10.1046/j.1524-4725.2002.02006.x
25. Horst C, Kapur N. Propranolol: a novel treatment for angiolymphoid hyperplasia with eosinophilia. Clin Exp Dermatol. 2014;39(7):810-812. doi:10.1111/ced.12412
26. Chen H, Thompson LDR, Aguilera NSI, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2004;28(4):505-513. doi:10.1097/00000478-200404000-00010
27. Andreae J, Galle C, Magdorf K, et al. Severe atherosclerosis of the aorta and development of peripheral T-cell lymphoma in an adolescent with angiolymphoid hyperplasia with eosinophilia. Br J Dermatol. 2005;152(5):1033-1038. doi:10.1111/j.1365-2133.2005.06421.x
28. Chen JF, Gao HW, Wu BY, Tsai WC, Chiang CP. Angiolymphoid hyperplasia with eosinophilia affecting the scrotum: a rare case report with molecular evidence of T-cell clonality. J Dermatol 2010;37(4):355-359. doi:10.1111/j.1346-8138.2010.00818.x
29. Gonzalez-Cuyar LF, Tavora F, Zhao XF, et al. Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process. Diagn Pathol. 2008;3:22. doi:10.1186/1746-1596-3-22
30. Brenn T, Flencher CDM. Cutaneous Epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors. Am J Dermatopathol. 2004;26(1):14-21. doi:10.1097/00000372-200402000-00003
31. Lam YT, Hsu C-J, Simpson PJL, et al. Androgens stimulate EPC-mediated neovascularization and are associated with increased coronary collateralization. Endocrinology. 2020;161(5):1-13. doi:10.1210/endocr/bqaa043
32. Motamer M, Javanmard SH, Mortazavi ZS, Bahrani S. Evaluation of the effect of testosterone on the number of endothelial progenitor cells and amount of SDF-1a, PDGF, bFGF, and NO. Int J Prev Med. 2019;10:214. doi:10.4103/ijpvm.IJPVM_79_18
33. Chodari L, Mohammadi M, Ghorbanzadeh V, Dariushnejad H, Mohaddes G. Testosterone and voluntary exercise promote angiogenesis in hearts of rats with diabetes by enhancing expression of VEGF-A and SDF-1a. Can J Diabetes. 2016;40(5):436-441. doi:10.1016/j.jcjd.2016.03.004
34. Blackwood L, Chapman I, Lyon M, Hernandez C. Multifocal eruptive cutaneous epithelioid angiomatous nodules. JAAD Case Reports. 2016;2(6):454-456. doi:10.1016/j.jdcr.2016.09.013.
35. Luzar B, Calonje E. Update on cutaneous epithelioid vascular tumours. Diagnostic Histopathol. 2018;24(8):273-287. doi:10.1016/j.mpdhp.2018.06.002
36. Pavlidakey PG, Burroughs C, Karrs T, Somach SC. Cutaneous epithelioid angiomatous nodule: a case with metachronous lesions. Am J Dermatopathol. 2011;33(8):831-834. doi:10.1097/DAD.0b013e3181fef12c
37. Labbène I, Rammeh S, Znaidi N, Fazaa B, Zermani R. A case of multiple epithelioid angiomatous nodules. Dermatol Online J. 2012;18(8):8.
38. Dastgheib L, Aslani FS, Sepaskhak M, Saki N, Motevalli D. A young woman with multiple cutaneous epithelioid angiomatous nodules (CEAN) on her forearm: a case report and follow-up of therapeutic intervention. Dermatol Online J. 2013;19(3):1.